Part 2 of the Choosing the Right Disinfectant Series
By John Michael Weir | Environmental Services Professional
In the first post in this series, I laid out four variables that drive smart disinfectant selection: microbial targets, contact time, chemistry, and EPA registration. Each one deserves a deeper look. This post focuses on the first and most foundational: knowing exactly which organisms you are targeting and why that determines which disinfectant belongs in your team’s hands.
This is not an abstract exercise. The wrong product applied to the right surface is still the wrong choice. In healthcare environmental services, organism-specific disinfectant selection is a patient safety decision.
Why the Organism Determines the Product
Disinfectants do not kill all organisms equally. The structure of a pathogen determines how vulnerable it is to a given chemical agent. Bacteria with protective spore coats, fungi with thick cell walls, and non-enveloped viruses with protein capsids are all significantly harder to inactivate than vegetative bacteria or enveloped viruses. A product that delivers a 99.9% kill rate against MRSA may have zero efficacy against C. diff spores.
The hierarchy of microbial resistance, from easiest to hardest to kill, generally follows this order: enveloped viruses, vegetative bacteria, fungi, non-enveloped viruses, mycobacteria, and bacterial spores. Understanding where your target pathogen falls in that hierarchy directly informs the level of disinfection required and the chemistry needed to achieve it.
The Spaulding Classification and Environmental Surfaces
The Spaulding Classification system, established by Earle Spaulding in 1968 and still endorsed by the CDC and APIC, categorizes patient care items into three tiers based on infection risk. Critical items contact sterile tissue and require sterilization. Semi-critical items contact mucous membranes and require high-level disinfection. Non-critical items contact only intact skin and require intermediate- to low-level disinfection.
Environmental surfaces fall into the non-critical category. But that designation does not mean any product will do. Non-critical surfaces in healthcare settings still carry significant pathogen burden and serve as a documented transmission route for healthcare-associated infections (HAIs). The CDC estimates that on any given day, approximately 1 in 31 hospital patients has at least one HAI. Environmental surface contamination is a contributing factor that EVS teams directly control.
The practical takeaway for EVS leaders: intermediate-level disinfection is the floor for most clinical areas, and organism-specific threats in your facility may require you to go higher.
Clostridioides difficile (C. diff)
Why it demands special attention
C. diff is a spore-forming bacterium and one of the most common causes of healthcare-associated diarrhea and colitis. According to the CDC, C. diff infects nearly 500,000 Americans annually and contributes to approximately 15,000 to 30,000 deaths. The spores it produces are uniquely hardy: they can survive on environmental surfaces for months, resist heat, and are unaffected by alcohol-based hand rubs and most standard disinfectants.
What the science says about disinfectant choice
The only EPA-registered disinfectants effective against C. diff spores are sporicidal agents, primarily sodium hypochlorite (bleach) at concentrations of 1,000 to 5,000 ppm, and a small number of other sporicidal chemistries. Quaternary ammonium compounds, the most widely used disinfectant class in healthcare, have no sporicidal activity and should not be used as the primary disinfectant in C. diff isolation rooms or during outbreak response.
EPA List K identifies disinfectants registered for use against C. diff spores. Verify that any product used in C. diff precaution environments carries this registration. During active C. diff cases, your facility’s infection prevention team should define the disinfectant protocol, concentration, and frequency. EVS’s role is to execute that protocol with precision and consistency.
Candida auris
An emerging threat with real environmental implications
Candida auris is a multidrug-resistant fungus first identified in 2009 and now present across multiple continents. The CDC has designated it a serious global health threat. What makes C. auris particularly relevant for EVS teams is its documented persistence on surfaces: research has detected C. auris on bedrails, windowsills, IV poles, and medical equipment days to weeks after a patient has left the room.
Disinfectant selection considerations
Not all disinfectants are effective against C. auris, and this is a critical point. Quaternary ammonium compounds, again, may not provide adequate efficacy. EPA List P identifies products with registered efficacy against C. auris. Accelerated hydrogen peroxide and sodium hypochlorite at appropriate concentrations are among the chemistries with demonstrated activity against this organism.
If your facility has had a confirmed C. auris case, your infection prevention team should be driving the disinfectant protocol. If you have not yet had a case, knowing which products on your current formulary hold EPA List P registration is a preparedness step worth taking now.
MRSA, VRE, and CRE
The resistant bacteria most EVS teams encounter regularly
Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and carbapenem-resistant Enterobacteriaceae (CRE) are among the most common multidrug-resistant organisms (MDROs) found in hospital environments. Unlike C. diff, these are vegetative bacteria without spore-forming capability, which means they are more susceptible to a broader range of disinfectant chemistries.
Intermediate-level disinfectants with documented efficacy against these organisms, applied at the correct contact time, are generally adequate for terminal cleaning and daily disinfection of contact precaution rooms. The key variables are not the chemistry but the application: adequate surface coverage, correct product dilution, and adherence to contact time.
Where EVS teams can improve outcomes
Research consistently shows that high-touch surfaces in MDRO isolation rooms are frequently missed or inadequately disinfected. Studies using fluorescent markers and ATP bioluminescence have demonstrated that bed rails, call buttons, light switches, toilet handles, and door handles are among the most missed surfaces during terminal cleaning. Product efficacy is irrelevant if the product is not reaching the surface. Training, monitoring, and accountability systems are as important as the disinfectant itself.
Norovirus and SARS-CoV-2
Non-enveloped versus enveloped viruses
Understanding viral structure matters for disinfectant selection. Enveloped viruses, including SARS-CoV-2, influenza, and RSV, have a lipid outer membrane that is relatively easy to disrupt. Most intermediate-level disinfectants, including quats, AHP, and bleach, are effective against enveloped viruses at standard concentrations and contact times.
Norovirus is a non-enveloped virus, which makes it significantly more resistant to disinfection. It is also highly contagious, with as few as 18 viral particles sufficient to cause infection in a susceptible host. In healthcare settings, norovirus outbreaks can move quickly through a unit if environmental disinfection is inadequate.
EPA List guidance
For norovirus, look for EPA List Q registration, which identifies products effective against norovirus surrogates. For SARS-CoV-2 and other emerging viral pathogens, EPA List N is the reference. Many current healthcare disinfectants carry List N registration, but List Q is a more selective list. Verify both before assuming your current product covers viral threats across the board.
Putting It Into Practice: A Framework for EVS Leaders
The organisms above are not hypothetical. They are present in hospitals every day. An EVS leader’s job is to ensure that the disinfectant being applied to a surface is capable of addressing the organism that surface may be harboring. That requires four things:
- Know the organisms: Work with your infection preventionist to understand which pathogens are active in your facility and which areas carry the highest risk.
- Know your product’s registration: Pull the EPA registration for every disinfectant in your formulary. Match it to the EPA lists relevant to your facility’s pathogen profile.
- Align product to environment: Do not use the same product everywhere by default. C. diff rooms, C. auris cases, and standard MDRO precaution rooms may each call for a different product or protocol.
- Train to the organism: When staff understand why a specific product is required in a specific room, compliance improves. Context drives behavior.
What Comes Next
The next post in this series focuses on wet contact time: what it means, why compliance is so poor in most facilities, and what EVS leaders can do to close that gap. It is one of the most actionable areas in the entire disinfection process, and one of the most overlooked.
John Michael Weir has 28 years of experience in hospital environmental services, having served in frontline, supervisor, manager, director, and multi-site director roles. He writes at www.johnmichaelweir.com.